Potential first-ever drug for preeclampsia begins late-stage testing

A Framingham company is planning a late-stage trial of what it hopes will be the first-ever drug to treat the potentially deadly pregnancy disease, preeclampsia. First described by Hippocrates around 400 B.C., preeclampsia has been fatal to mothers and babies for centuries, surfacing in the World War I-era PBS drama, “Downton Abbey.” While it is known to cause a rapid rise in blood pressure that may lead to seizure, stroke or organ failure, Yann Echelard, CEO of rEVO Biologics, said that as…
Source: bizjournals.com Health Care:Hospitals headlines - Category: Hospital Management Authors: Source Type: research